$USPH
U S PHYSICAL THERAPY INC /NV

2013 Q3 Form 10-Q Financial Statement

#000119312513432507 Filed on November 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q3
Revenue $65.83M $62.10M
YoY Change 6.0% 4.02%
Cost Of Revenue $49.70M $46.70M
YoY Change 6.42% 1.74%
Gross Profit $16.13M $15.44M
YoY Change 4.44% 11.9%
Gross Profit Margin 24.5% 24.87%
Selling, General & Admin $6.200M $5.900M
YoY Change 5.08% 15.69%
% of Gross Profit 38.44% 38.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.450M $1.370M
YoY Change 5.84% 0.74%
% of Gross Profit 8.99% 8.87%
Operating Expenses $6.200M $5.900M
YoY Change 5.08% 15.69%
Operating Profit $9.904M $9.534M
YoY Change 3.88% 9.59%
Interest Expense $133.0K $142.0K
YoY Change -6.34% -242.0%
% of Operating Profit 1.34% 1.49%
Other Income/Expense, Net
YoY Change
Pretax Income $9.773M $9.394M
YoY Change 4.03% 10.52%
Income Tax $3.017M $2.992M
% Of Pretax Income 30.87% 31.85%
Net Earnings $227.0K $4.563M
YoY Change -95.03% 11.29%
Net Earnings / Revenue 0.34% 7.35%
Basic Earnings Per Share $0.02 $0.39
Diluted Earnings Per Share $0.02 $0.38
COMMON SHARES
Basic Shares Outstanding 12.11M shares 12.11M shares
Diluted Shares Outstanding 12.12M shares 12.12M shares

Balance Sheet

Concept 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.10M $10.70M
YoY Change 13.08% 12.63%
Cash & Equivalents $12.12M $10.68M
Short-Term Investments
Other Short-Term Assets $4.482M $5.000M
YoY Change -10.36% -19.35%
Inventory
Prepaid Expenses
Receivables $28.60M $28.40M
Other Receivables $0.00 $0.00
Total Short-Term Assets $45.16M $44.10M
YoY Change 2.4% -3.71%
LONG-TERM ASSETS
Property, Plant & Equipment $13.52M $12.80M
YoY Change 5.59% -5.88%
Goodwill $105.2M
YoY Change
Intangibles $14.67M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.078M $1.000M
YoY Change 7.8% -70.59%
Total Long-Term Assets $134.5M $125.8M
YoY Change 6.92% 6.43%
TOTAL ASSETS
Total Short-Term Assets $45.16M $44.10M
Total Long-Term Assets $134.5M $125.8M
Total Assets $179.7M $169.9M
YoY Change 5.74% 3.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.300M $1.700M
YoY Change -23.53% -5.56%
Accrued Expenses $14.78M $12.70M
YoY Change 16.37% 12.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $575.0K $600.0K
YoY Change -4.17% 20.0%
Total Short-Term Liabilities $16.66M $14.90M
YoY Change 11.78% 8.76%
LONG-TERM LIABILITIES
Long-Term Debt $14.55M $16.30M
YoY Change -10.74% -39.18%
Other Long-Term Liabilities $728.0K $2.300M
YoY Change -68.35% 64.29%
Total Long-Term Liabilities $15.28M $18.60M
YoY Change -17.86% -34.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.66M $14.90M
Total Long-Term Liabilities $15.28M $18.60M
Total Liabilities $32.95M $50.50M
YoY Change -34.76% -17.21%
SHAREHOLDERS EQUITY
Retained Earnings $116.6M
YoY Change
Common Stock $39.37M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $31.63M
YoY Change
Treasury Stock Shares 2.215M shares
Shareholders Equity $124.3M $119.4M
YoY Change
Total Liabilities & Shareholders Equity $179.7M $169.9M
YoY Change 5.74% 3.6%

Cashflow Statement

Concept 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $227.0K $4.563M
YoY Change -95.03% 11.29%
Depreciation, Depletion And Amortization $1.450M $1.370M
YoY Change 5.84% 0.74%
Cash From Operating Activities $8.140M $10.38M
YoY Change -21.58% 33.94%
INVESTING ACTIVITIES
Capital Expenditures -$1.070M -$1.010M
YoY Change 5.94% -94.92%
Acquisitions
YoY Change
Other Investing Activities -$300.0K -$540.0K
YoY Change -44.44% -106.98%
Cash From Investing Activities -$1.370M -$1.550M
YoY Change -11.61% -87.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.940M -6.960M
YoY Change -29.02% -242.92%
NET CHANGE
Cash From Operating Activities 8.140M 10.38M
Cash From Investing Activities -1.370M -1.550M
Cash From Financing Activities -4.940M -6.960M
Net Change In Cash 1.830M 1.870M
YoY Change -2.14% 289.58%
FREE CASH FLOW
Cash From Operating Activities $8.140M $10.38M
Capital Expenditures -$1.070M -$1.010M
Free Cash Flow $9.210M $11.39M
YoY Change -19.14% -58.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3628000
CY2012Q2 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.70 pure
CY2012Q2 usph Percentage Of Tax Deductible Goodwill
PercentageOfTaxDeductibleGoodwill
0.70 pure
CY2012Q2 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
250000
us-gaap Income Tax Effects Allocated Directly To Equity Equity Transactions
IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions
34000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
1700000
CY2013Q1 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1.00 pure
CY2013Q1 us-gaap Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value
BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
5428000
CY2013Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
719000
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737 shares
CY2013Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
1342000
CY2013Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-264000
CY2013Q1 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
13399000
CY2013Q1 usph Payments To Acquire Businesses Consideration
PaymentsToAcquireBusinessesConsideration
10928000
CY2013Q1 usph Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill Net
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwillNet
160000
CY2013Q1 usph Business Acquisition Purchase Price Allocation Referral Relationships
BusinessAcquisitionPurchasePriceAllocationReferralRelationships
400000
CY2013Q1 usph Business Combination Cost Of Acquire Entity Purchase Price
BusinessCombinationCostOfAcquireEntityPurchasePrice
5000
CY2013Q1 usph Business Acquisition Purchase Price Allocation Trade Name
BusinessAcquisitionPurchasePriceAllocationTradeName
600000
CY2013Q1 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
800000
CY2013Q1 usph Business Acquisition Purchase Price Allocation Net Tangible Asset
BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
1797000
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12106820 shares
CY2009Q1 usph Purchase Of Common Stock Under Credit Agreement
PurchaseOfCommonStockUnderCreditAgreement
15000000
CY2009Q1 usph Maximum Percentage Of Repurchase Of Common Stock
MaximumPercentageOfRepurchaseOfCommonStock
0.10 pure
CY2009Q1 usph Repurchases Of Common Stock
RepurchasesOfCommonStock
1200000 shares
CY2009Q1 usph Bank Credit Agreement To Permit Share Repurchases Of Common Stock
BankCreditAgreementToPermitShareRepurchasesOfCommonStock
15000000
CY2012Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10683000
CY2013Q3 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1.00 pure
CY2013Q3 usph Business Combination Cost Of Acquire Entity Purchase Price
BusinessCombinationCostOfAcquireEntityPurchasePrice
95000
CY2013Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
43 State
CY2013Q3 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1.00 pure
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14321557 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14779000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
CY2013Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14550000
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
46150000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16655000
CY2013Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
600000
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
146709000
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
728000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
124295000
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39225000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
575000
CY2013Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q3 us-gaap Minority Interest
MinorityInterest
22414000
CY2013Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
14150000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
116555000
CY2013Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1301000
CY2013Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1015000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
143000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
179657000
CY2013Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
400000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
14550000
CY2013Q3 us-gaap Long Term Debt
LongTermDebt
15125000
CY2013Q3 us-gaap Liabilities
Liabilities
32948000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
575000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
45157000
CY2013Q3 us-gaap Goodwill
Goodwill
105234000
CY2013Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
22170000
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14672000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1078000
CY2013Q3 us-gaap Assets
Assets
179657000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12123000
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
59666000
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4482000
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13516000
CY2013Q3 usph Allowance For Doubtful Accounts Accounts Receivable Other
AllowanceForDoubtfulAccountsAccountsReceivableOther
198000
CY2013Q3 usph Number Of Clinics Operated
NumberOfClinicsOperated
447 Clinic
CY2013Q3 usph Line Of Credit Facility Special Dividend Payable
LineOfCreditFacilitySpecialDividendPayable
0.40
CY2013Q3 usph Accounts Receivable Other
AccountsReceivableOther
1263000
CY2013Q3 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02 pure
CY2013Q3 usph Furniture And Equipment Gross
FurnitureAndEquipmentGross
37496000
CY2013Q3 usph Business Acquisition Purchase Price Allocation Referral Relationships
BusinessAcquisitionPurchasePriceAllocationReferralRelationships
800000
CY2013Q3 usph Patient Accounts Receivable
PatientAccountsReceivable
27289000
CY2013Q3 usph Leverage Ratios
LeverageRatios
Less than 1.0 to 1.0
CY2013Q3 usph Business Combination Cost Of Acquire Entity Purchase Price
BusinessCombinationCostOfAcquireEntityPurchasePrice
130000
CY2013Q3 usph Business Acquisition Purchase Price Allocation Trade Name
BusinessAcquisitionPurchasePriceAllocationTradeName
1300000
CY2013Q3 usph Allowance For Doubtful Accounts Patient Accounts Receivable
AllowanceForDoubtfulAccountsPatientAccountsReceivable
1427000
CY2008Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2250000 shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9983000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14129651 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14116000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
17575000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44158000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16307000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134659000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2279000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
117323000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
37489000
CY2012Q4 us-gaap Minority Interest
MinorityInterest
17336000
CY2012Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
17400000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
111321000
CY2012Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1732000
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
894000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
141000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
171714000
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
175000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
18034000
CY2012Q4 us-gaap Liabilities
Liabilities
37055000
CY2012Q4 us-gaap Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value
BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
2892000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
459000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
478000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
45322000
CY2012Q4 us-gaap Goodwill
Goodwill
100188000
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
20858000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12146000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1042000
CY2012Q4 us-gaap Assets
Assets
171714000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
363000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11671000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
265000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57174000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-331000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5975000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2012Q4 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
8239000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13016000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29005000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4402000
CY2012Q4 usph Payments To Acquire Businesses Consideration
PaymentsToAcquireBusinessesConsideration
8279000
CY2012Q4 usph Allowance For Doubtful Accounts Accounts Receivable Other
AllowanceForDoubtfulAccountsAccountsReceivableOther
514000
CY2012Q4 usph Accounts Receivable Other
AccountsReceivableOther
1703000
CY2012Q4 usph Furniture And Equipment Gross
FurnitureAndEquipmentGross
36316000
CY2012Q4 usph Business Acquisition Purchase Price Allocation Referral Relationships
BusinessAcquisitionPurchasePriceAllocationReferralRelationships
857000
CY2012Q4 usph Patient Accounts Receivable
PatientAccountsReceivable
25973000
CY2012Q4 usph Business Acquisition Purchase Price Allocation Trade Name
BusinessAcquisitionPurchasePriceAllocationTradeName
1300000
CY2012Q4 usph Allowance For Doubtful Accounts Patient Accounts Receivable
AllowanceForDoubtfulAccountsPatientAccountsReceivable
1595000
CY2012Q4 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
350000
CY2012Q4 usph Business Acquisition Purchase Price Allocation Net Tangible Asset
BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
510000
CY2013Q3 usph Facilities Previously Closed
FacilitiesPreviouslyClosed
1 Facility
dei Trading Symbol
TradingSymbol
USPH
dei Entity Registrant Name
EntityRegistrantName
U S PHYSICAL THERAPY INC /NV
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000885978
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12069000 shares
us-gaap Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
2015-08-31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
19000 shares
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.39
us-gaap Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
2011-08-31
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28859000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.13
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12050000 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Prior period amounts have been reclassified to conform to current period presentation due to discontinued operations.
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
459000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.12
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
859499 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> U<b>se of Estimates</b></p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In preparing the Company&#x2019;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, purchase accounting, goodwill impairment, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</p> </div>
us-gaap Interest Paid Net
InterestPaidNet
352000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
5428000
us-gaap Gross Profit
GrossProfit
48563000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4965000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10128000
us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
6013000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
91700000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-4727000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
47000
us-gaap Profit Loss
ProfitLoss
15242000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1148000
us-gaap Operating Income Loss
OperatingIncomeLoss
29398000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
4426000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
13589000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
6588000
us-gaap Net Income Loss
NetIncomeLoss
8862000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
191027000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
20207000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
277000
us-gaap Sales Revenue Net
SalesRevenueNet
195453000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3458000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6380000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-899000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
13399000
us-gaap Costs And Expenses
CostsAndExpenses
146890000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
47000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13601000
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
277000
us-gaap Dividends Common Stock
DividendsCommonStock
3628000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-277000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-543000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6588000
us-gaap Share Based Compensation
ShareBasedCompensation
2092000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3390000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
452000
us-gaap Interest Expense
InterestExpense
398000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
1068000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14806000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
664000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
88450000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4181000
us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
112000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
693000
us-gaap Restructuring Charges
RestructuringCharges
21000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
105318000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8798000
usph Share Based Compensation Arrangement By Share Based Payment Share Granted To Employees Lapse In Equal Installments Description
ShareBasedCompensationArrangementByShareBasedPaymentShareGrantedToEmployeesLapseInEqualInstallmentsDescription
Shares granted to employees lapse in equal installments on the following four or five annual anniversaries of the date of grant.
usph Reduction In Medicare Spending Percentage
ReductionInMedicareSpendingPercentage
0.02 pure
usph Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest Percent By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestPercentByParent
0.01 pure
usph Increase Decrease In Accounts Receivable Other
IncreaseDecreaseInAccountsReceivableOther
41000
usph Percentage Of General Partnership Interest Owned
PercentageOfGeneralPartnershipInterestOwned
0.01 pure
usph Treasury Stock Shares Retirement Period
TreasuryStockSharesRetirementPeriod
P7D
usph Additional Estimated Repurchase Of Common Stock
AdditionalEstimatedRepurchaseOfCommonStock
340501 shares
usph Maximum Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage
MaximumDifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
0.01 pure
usph Percentage Reduction For Service In Office Or Other Non Institutional Settings
PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings
0.20 pure
usph Compensation Expense Restricted Stock
CompensationExpenseRestrictedStock
2092000
usph Effective Date Of Reduction In Medicare Physician Fee Payment Rate
EffectiveDateOfReductionInMedicarePhysicianFeePaymentRate
2013-04-01
usph Acquisitions Of Noncontrolling Interests
AcquisitionsOfNoncontrollingInterests
1668000
usph Amount Of Reductions In Federal Spending
AmountOfReductionsInFederalSpending
1200000000000
usph Number Of Separate Transactions To Purchase Partnership Interest
NumberOfSeparateTransactionsToPurchasePartnershipInterest
7 Transactions
usph Number Of Clinic Acquired
NumberOfClinicAcquired
1 Clinic
usph Percentage Increase In Payment Reduction In Institutional Or Non Institutional Setting
PercentageIncreaseInPaymentReductionInInstitutionalOrNonInstitutionalSetting
0.50 pure
usph Percentage Of Limited Partnership Interest Owned
PercentageOfLimitedPartnershipInterestOwned
0.64 pure
usph Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues
DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
0.01 pure
usph Business Acquisition Cost Of Acquired Entity Charge From Undistributed Earning
BusinessAcquisitionCostOfAcquiredEntityChargeFromUndistributedEarning
142000
usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
248000
usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
800000
usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
5 Partnership
usph Interest And Other Income Net
InterestAndOtherIncomeNet
5000
usph Increase Decrease In Patient Accounts Receivable
IncreaseDecreaseInPatientAccountsReceivable
3318000
usph Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Amount Changes Purchase Consideration Charge From Undistributed Earning
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestAmountChangesPurchaseConsiderationChargeFromUndistributedEarning
1600000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
284000
usph Goodwill Allocated To Specific Assets
GoodwillAllocatedToSpecificAssets
2340000
usph Minimum Difference Between Actual Aggregate Contractual Reserve Percentages Compared To Estimated Contractual Allowance Reserve Percentage
MinimumDifferenceBetweenActualAggregateContractualReservePercentagesComparedToEstimatedContractualAllowanceReservePercentage
0.01 pure
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-184000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7402000
usph Proceeds From Sale Of Non Controlling Interest Fixed Assets And Business
ProceedsFromSaleOfNonControllingInterestFixedAssetsAndBusiness
448000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
63300000
usph Rent Clinic Supplies Contract Labor And Other
RentClinicSuppliesContractLaborAndOther
38161000
usph Loss On Sale Or Abandonment Of Assets Net
LossOnSaleOrAbandonmentOfAssetsNet
7233000
usph Percentage Reduction For Service In Institutional Settings
PercentageReductionForServiceInInstitutionalSettings
0.25 pure
usph Period Of Federal Debt Ceiling In Connection With Deficit Reductions
PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions
P10Y
usph Stock Issued During Period Value Restricted Stock Award Gross Shares Shares
StockIssuedDuringPeriodValueRestrictedStockAwardGrossSharesShares
0 shares
usph Corporate Office Costs
CorporateOfficeCosts
19165000
usph Percentage Of Practice Expense Component Of Relative Value Unit
PercentageOfPracticeExpenseComponentOfRelativeValueUnit
1.00 pure
usph Percentage Of Reduction Prevented
PercentageOfReductionPrevented
0.265 pure
usph Minimum Percentage Of Fair Value Reporting Unit Less Than Carrying Amount
MinimumPercentageOfFairValueReportingUnitLessThanCarryingAmount
0.50 pure
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.17
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11892000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
114000 shares
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29350000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.19
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11778000 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.18
us-gaap Interest Paid Net
InterestPaidNet
538000
us-gaap Gross Profit
GrossProfit
48531000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29660000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5200000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3183000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-92000
us-gaap Profit Loss
ProfitLoss
20424000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-471000
us-gaap Operating Income Loss
OperatingIncomeLoss
30105000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
4222000
us-gaap Sales Revenue Net
SalesRevenueNet
187270000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2948000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
13982000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6534000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1709000
us-gaap Costs And Expenses
CostsAndExpenses
138739000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
6850000
us-gaap Net Income Loss
NetIncomeLoss
13890000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
183048000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
20608000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
53000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17283000
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
381000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-381000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2535000
us-gaap Share Based Compensation
ShareBasedCompensation
1589000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3638000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4016000
us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
658000
us-gaap Restructuring Charges
RestructuringCharges
76000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
97974000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9052000
usph Acquisitions Of Noncontrolling Interests
AcquisitionsOfNoncontrollingInterests
1314000
usph Increase Decrease In Accounts Receivable Other
IncreaseDecreaseInAccountsReceivableOther
482000
usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
350000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
700000
us-gaap Interest Expense
InterestExpense
449000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11367000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
400000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
55900000
usph Interest And Other Income Net
InterestAndOtherIncomeNet
4000
usph Increase Decrease In Patient Accounts Receivable
IncreaseDecreaseInPatientAccountsReceivable
1298000
usph Rent Clinic Supplies Contract Labor And Other
RentClinicSuppliesContractLaborAndOther
37051000
usph Loss On Sale Or Abandonment Of Assets Net
LossOnSaleOrAbandonmentOfAssetsNet
129000
usph Corporate Office Costs
CorporateOfficeCosts
18426000
usph Proceeds From Sale Of Non Controlling Interest Fixed Assets And Business
ProceedsFromSaleOfNonControllingInterestFixedAssetsAndBusiness
297000
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10128000
CY2012Q2 usph Number Of Clinic Acquired
NumberOfClinicAcquired
7 Clinic
CY2012Q4 usph Facilities Previously Closed
FacilitiesPreviouslyClosed
1 Facility
CY2013Q1 usph Percentage Reduction To Medicare Physical Fee Schedule Payment Rates
PercentageReductionToMedicarePhysicalFeeSchedulePaymentRates
0.244 pure
CY2013Q1 usph Percentage Aggregate Positive Impact On Services
PercentageAggregatePositiveImpactOnServices
0.01 pure
CY2012 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
7 Clinic
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7929000
CY2012 usph Number Of Outpatient Therapy Practices Purchased
NumberOfOutpatientTherapyPracticesPurchased
7 Transactions
CY2012 usph Number Of Transaction For Notes Payable Purchased
NumberOfTransactionForNotesPayablePurchased
1 Transactions
CY2012Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.00
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2012Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.09
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11928000 shares
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
101000 shares
CY2012Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.00
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.39
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11827000 shares
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.38
CY2012Q3 us-gaap Gross Profit
GrossProfit
15442000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9394000
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-104000
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-59000
CY2012Q3 us-gaap Profit Loss
ProfitLoss
6298000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9535000
CY2012Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
1383000
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4622000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
4563000
CY2013Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
1461000
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4659000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
227000
CY2013Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
64368000
CY2013Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
6756000
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
65829000
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2032000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
49701000
CY2013Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1095000
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
196000
CY2012Q3 us-gaap Restructuring Charges
RestructuringCharges
5000
CY2013Q3 us-gaap Interest Expense
InterestExpense
133000
CY2012Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
60719000
CY2012Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
6402000
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
62102000
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1735000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
46660000
CY2012Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1250000
CY2012Q3 us-gaap Interest Expense
InterestExpense
142000
CY2012Q3 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2012Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
33037000
CY2012Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2992000
CY2012Q3 usph Interest And Other Income Net
InterestAndOtherIncomeNet
1000
CY2012Q3 usph Rent Clinic Supplies Contract Labor And Other
RentClinicSuppliesContractLaborAndOther
12368000
CY2012Q3 usph Corporate Office Costs
CorporateOfficeCosts
5907000
CY2013Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.36
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12120000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
14000 shares
CY2013Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.36
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.38
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12106000 shares
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.38
CY2013Q3 us-gaap Gross Profit
GrossProfit
16128000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9773000
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4497000
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-4432000
CY2013Q3 us-gaap Profit Loss
ProfitLoss
2259000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9904000
CY2013Q3 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
236000
CY2013Q3 us-gaap Restructuring Charges
RestructuringCharges
-5000
CY2013Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
35733000
CY2013Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3017000
CY2013Q3 usph Interest And Other Income Net
InterestAndOtherIncomeNet
2000
CY2013Q3 usph Rent Clinic Supplies Contract Labor And Other
RentClinicSuppliesContractLaborAndOther
12878000
CY2013Q3 usph Corporate Office Costs
CorporateOfficeCosts
6224000

Files In Submission

Name View Source Status
0001193125-13-432507-index-headers.html Edgar Link pending
0001193125-13-432507-index.html Edgar Link pending
0001193125-13-432507.txt Edgar Link pending
0001193125-13-432507-xbrl.zip Edgar Link pending
d611615d10q.htm Edgar Link pending
d611615dex311.htm Edgar Link pending
d611615dex312.htm Edgar Link pending
d611615dex313.htm Edgar Link pending
d611615dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usph-20130930.xml Edgar Link completed
usph-20130930.xsd Edgar Link pending
usph-20130930_cal.xml Edgar Link unprocessable
usph-20130930_def.xml Edgar Link unprocessable
usph-20130930_lab.xml Edgar Link unprocessable
usph-20130930_pre.xml Edgar Link unprocessable